You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ichthyosis

Showing 26 - 50 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neutrophil Proteases As Global Regulators Of Il-1 Family

Recruiting
  • Psoriasis Vulgaris
  • +2 more
  • No intervention
  • Dublin, Ireland
    Clinical Research Facility, St James Hospital
Mar 2, 2021

Ichthyosis Trial in Toulouse (Therapeutic patient education program)

Unknown status
  • Ichthyosis
  • Therapeutic patient education program
  • Toulouse, France
    CHU Toulouse, Hôpital Larrey
Aug 24, 2020

A Multi-center, Prospective Evaluation of Infants and Congenital

Terminated
  • Ichthyosis
  • Observation
  • New Haven, Connecticut
    Yale School of Medicine
Jul 6, 2020

Ichthyosis, Pruritus Trial in New York (Avena Sativa Skincare Regimen)

Completed
  • Ichthyosis
  • Pruritus
  • Avena Sativa Skincare Regimen
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Nov 2, 2020

Atopic Dermatitis, Ichthyosis, Psoriasis Trial in Chicago (Itch Questionnaire and Interview, Stigma Questionnaire and Interview,

Completed
  • Atopic Dermatitis
  • +2 more
  • Itch Questionnaire and Interview
  • +2 more
  • Chicago, Illinois
    Department of Dermatology, Northwestern University Feinberg Scho
Oct 8, 2020

Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Tumor, Lynch Syndrome Trial in Canada,

Withdrawn
  • Constitutional Mismatch Repair Deficiency Syndrome
  • +11 more
  • Biospecimen Collection
  • +2 more
  • Palo Alto, California
  • +8 more
Sep 9, 2022

Ichthyosis Vulgaris Trial in Aarhus (7.5 %)

Unknown status
  • Ichthyosis Vulgaris
  • 7.5 %
  • Aarhus, Denmark
    Department of Dermatology, Aarhus University Hospital
Oct 29, 2019

Xeroderma Pigmentosum Trial in London (XPAND)

Completed
  • Xeroderma Pigmentosum
  • XPAND
  • London, United Kingdom
    Guy's St Thomas' NHS Foundation Trust
Jul 21, 2020

Netherton Syndrome Trial (Spesolimab - solution for infusion, Placebo matching to spesolimab - solution for infusion, Spesolimab

Not yet recruiting
  • Netherton Syndrome
  • Spesolimab - solution for infusion
  • +3 more
  • (no location specified)
May 11, 2023

Netherton Syndrome Trial in New Haven (ATR12-351)

Not yet recruiting
  • Netherton Syndrome
  • New Haven, Connecticut
    Yale University
Nov 13, 2023

Sjogren-Larsson Syndrome Trial in Omaha (ADX-629)

Recruiting
  • Sjogren-Larsson Syndrome
  • Omaha, Nebraska
    University of Nebraska Medical Center
Nov 7, 2022

Xerosis Due to Atopic Dermatitis Trial in Winston-Salem (Cetaphil Pro Eczema moisturizer, Electronic interaction, GPSkin)

Active, not recruiting
  • Xerosis Due to Atopic Dermatitis
  • Cetaphil Pro Eczema moisturizer
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences Department of Dermatology
Dec 21, 2022

Natural History of Netherton Syndrome

Not yet recruiting
  • Netherton Syndrome
    • (no location specified)
    Jun 21, 2023

    Netherton Syndrome Trial in Paris (DS-2325a, Placebo)

    Not yet recruiting
    • Netherton Syndrome
    • Paris, France
      Saint Louis Hospital
    Jul 31, 2023

    Sphingolipidoses, Enzyme Deficiency Trial in San Francisco (no intervention)

    Recruiting
    • Sphingolipidoses
    • Enzyme Deficiency
    • no intervention
    • San Francisco, California
      University of California San Francisco
    Jul 1, 2022

    Nasal Injury Trial in Ordu (Hydrocolloid barrier group, Facial Massage group)

    Recruiting
    • Nasal Injury
    • Hydrocolloid barrier group
    • Facial Massage group
    • Ordu, Turkey
      Dilek alemdar
    May 3, 2023

    Skin Condition Trial in Cheras, Petaling Jaya (Rice ceramide supplementation)

    Completed
    • Skin Condition
    • Rice ceramide supplementation
    • Cheras, Kuala Lumpur, Malaysia
    • +1 more
    Sep 27, 2022

    Ichthyosis Trial in Toulouse (ophthalmological examination)

    Unknown status
    • Ichthyosis
    • ophthalmological examination
    • Toulouse, France
      University Hospital of Toulouse
    Mar 7, 2018

    Sjogren-Larsson Syndrome Trial in New Haven, Omaha (ADX-102 1% Topical Dermal Cream (reproxalap), Vehicle of ADX-102 Topical

    Completed
    • Sjogren-Larsson Syndrome
    • ADX-102 1% Topical Dermal Cream (reproxalap)
    • Vehicle of ADX-102 Topical Dermal Cream
    • New Haven, Connecticut
    • +1 more
    Nov 5, 2020

    Acute Myeloid Leukemia Trial in Tokyo (OCV-501)

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Tokyo, Japan
      National Cancer Center
    Feb 10, 2021

    Peripheral T-cell Lymphoma Trial in Worldwide (Pralatrexate Injection)

    Terminated
    Has Results
    • Peripheral T-cell Lymphoma
    • Pralatrexate Injection
    • Novi, Michigan
    • +54 more
    Nov 18, 2021

    Hernia Trial in Lexington, Albany, Greenville (acellular porcine dermal collagen mesh)

    Terminated
    Has Results
    • Hernia
    • acellular porcine dermal collagen mesh
    • Lexington, Kentucky
    • +2 more
    Nov 15, 2020

    Hand Eczema, Foot Eczema Trial in New York (Retapamulin 1% ointment, Placebo)

    Completed
    Has Results
    • Hand Eczema
    • Foot Eczema
    • Retapamulin 1% ointment
    • Placebo
    • New York, New York
      Mount Sinai School of Medicine
    Dec 2, 2020

    Treatment of Atopic Dermatitis in the United Kingdom (UK)

    Unknown status
    • Atopic Dermatitis Eczema
    • +2 more
    • No intervention
    • London, United Kingdom
      Momentum Data Ltd
    Jan 14, 2020

    Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose

    Completed
    Has Results
    • Solid Tumor
    • Derazantinib low dose range
    • +3 more
    • Scottsdale, Arizona
    • +11 more
    Mar 7, 2022